期刊文献+

阿达木单抗治疗类风湿关节炎药物经济学评价进展 被引量:2

原文传递
导出
摘要 阿达木单抗是特异性针对TNFⅨ的全人单克隆抗体,在欧美等国已经获批用于类风湿关节炎(RA)、强直性脊柱炎、银屑病、银屑病性关节炎、克罗恩病和幼年特发型关节炎的治疗。在我国,现已批准用于治疗改善病情抗风湿药(DMARDs)疗效不佳的成人中重度活动性RA。已有临床试验证明,生物制剂比传统药物治疗RA效果明显,
作者 蒋虹丽
出处 《中华内科杂志》 CAS CSCD 北大核心 2011年第4期351-354,共4页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献25

  • 1类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270. 被引量:1290
  • 2Bimbaum H,Pike C,Kaufman R,et al.Societal cost of rheumatoid arthritis patients in the US.Curt Med Res Opin,2010,26:77-90.
  • 3Yelin E,Wanke LA.An assessment of the annual and long-term direct costs of rheumatoid arthritis:the impact of poor function and functional decline.Arthritis Rheum,1999,42:1209-1218.
  • 4Pugner KM,Scott DI,Holmes JW,et al.The costs of rheumatoid arthritis:an international long-term view.Semin Arthritis Rheum,2000,29:305 -320.
  • 5Birnbaum HG,Barton M,Greenberg PE,et al.Direct and indirect costs of rheumatoid arthritis to an employer.J Occup Environ Med,2000,42:588-596.
  • 6Weinblatt ME,Keystone EC,Furst DE,et al.Adalimumab,a fully human anti-tumor necrosis factor alpha monoclonal antibody,for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate:the ARMADA trial.Arthritis Rheum,2003,48:35-45.
  • 7Weinblatt ME,Keystone EC,Furst DE,et al.Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis:ARMADA 4 year extended study.Ann Rheum Dis,2006,65:753-759.
  • 8Keystone EC,Kavanaugh AF,Sharp JT,et al.Radiographic,clinical,and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy:a randomized,placebo-controlled,52-week trial.Arthritis Rheum,2004,50:1400-1411.
  • 9Keystone EC,Kavanaugh A,van der Heijde D,et al.Long-term impact of adalimumab plus methotrexate on radiographic,clinical,and functional progression of rheumatoid arthritis.73rd Annual Scientific Meeting of the American College of Rheumatology (ACR) and the 44th Annual Meeting of the Association of Rheumatology Health Professionals (ARHP).Philadelphia,2009.
  • 10Breedveld FC,Weisman MH,Kavanaugh AF,et al.The PREMIER study:A multicenter,randomized,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early,aggressive rheumatoid arthritis who had not had previous methotrexate treatment.Arthritis Rheum,2006,54:26-37.

共引文献1289

同被引文献25

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部